Drugs / BLI4900
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03328507 | Nov 2017 → Nov 2019 | — | Braintree Laboratories | Completed | No outcome recorded |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT04446312 | Jul 2020 → Jan 2021 | — | Braintree Laboratories | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BLI4900 | “Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy” NCT04446312 ↗ |